Article: DOV Pharmaceutical, Inc. Announces Second Quarter 2003 Results.

DOV Pharmaceutical, Inc. today announced results for the second quarter ended June 30, 2003.

Second Quarter 2003 Performance

For the second quarter of 2003, the Company reported a net loss of $4.7 million, or $0.32 per share, compared with $3.8 million, or $0.32 per share, for the comparable period last year. For the six months ended June 30, 2003, the Company reported a net loss of $7.3 million, or $0.50 per share, compared with $7.7 million, or $0.91 per share, for the comparable period last year. At June 30, 2003, cash and cash equivalents and marketable securities totaled $54.2 million. In addition, on July 2, 2003, the Company concluded a private ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!